Clinical Trials Logo

Filter by:
NCT ID: NCT05896085 Completed - Emotion Regulation Clinical Trials

Game Based Assessment of Emotion-regulation Skills in College Students

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study will be to investigate the validity of the in-game performance measurements or scores as indicators of students'ER abilities.

NCT ID: NCT05779501 Completed - Clinical trials for Mental Health Wellness

Efficacy of Internet-delivered Strengths Use Intervention

Start date: February 15, 2023
Phase: N/A
Study type: Interventional

The aim of the study will be to test the efficacy of a novel online-delivered gamification-based intervention for the identification, development, and use of strengths in the workplace. The program will be addressed to young employees and will have the aim of boosting their well-being and performance.

NCT ID: NCT05749601 Completed - Knee Osteoarthritis Clinical Trials

Risk Factor Involved in Knee Osteoarthritis (KOA)

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Clinical study regarding the incidence and severity of knee osteoarthritis (KOA) in a certain area from South-Eastern Europe. Aim of the clinical study: to determine the KOA grade through X-Ray studies, to perform nuclear magnetic resonance (NMR) analysis to assess the KOA severity and to determine the level of significant parameters in the synovial liquid extracted from the patients presenting KOA.

NCT ID: NCT05737927 Completed - Obese Clinical Trials

Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects

Start date: September 16, 2020
Phase: Phase 1
Study type: Interventional

The goal of this clinical study was to assess pharmacodynamics (PD) and pharmacokinetics (PK) of different Glucose beads formulations in obese healthy subjects under fasting condition. The study was designed in 2 parts. Part 1 (single-dose) of the study was randomized, open label, five-treatment, five-period, five-sequence, crossover and single-centric. Treatment arms were three dosages of a coated Glucose beads formulation (47% w/w glucose/bead; 8 g [T1], 12 g [T2] and 16 g glucose [T3]), one uncoated Glucose beads formulation (47% w/w glucose/bead; 12 g glucose [T4]) and one coated Glucose beads formulation (60% w/w glucose/bead;12 g glucose [T5]). Part 2 (multiple-dose) of the study was open label, one-treatment, one-period and single-centric. Treatment arm was coated Glucose beads formulation (12 g glucose [T2]).

NCT ID: NCT05713773 Completed - Obesity Clinical Trials

Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects

Start date: October 25, 2019
Phase: Phase 1
Study type: Interventional

This single-dose, randomized, open label, five-treatment, five-period, five-sequence crossover study was performed to assess pharmacodynamics (PD) and pharmacokinetics (PK) of three new developed coated Glucose beads formulations (containing glucose (8 g) and caffeine), one coated Glucose beads formulation (containing glucose (8 g)) and one uncoated Glucose beads formulation (containing Glucose (8 g) and caffeine) after single-dose administration (fasting conditions) in 20 obese healthy subjects. After an overnight fasting of at least 10 hours the subjects were administered either glucose (8 g) or glucose (8 g) and caffeine starting at 8:00 (time 0; administration time was staggered beginning at 8:00 for the first group of subjects) in sitting position. At least 3 days wash-out period was kept between each treatment periods.

NCT ID: NCT05705011 Completed - Clinical trials for Cognitive Impairment

Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.

Start date: March 1, 2019
Phase:
Study type: Observational

This observational study explores the impact of cognitive impairment and frailty in older adults with advanced chronic kidney disease ]. The main question[s] it aims to answer are: - What determines the time to initiate dialysis? Cognitive impairment or frailty? - What does predict the time to death? Presence of frailty or cognitive impairment? - What does correlate strongly with time-low health-related quality of life? frailty or cognitive impairment?

NCT ID: NCT05668806 Completed - Vaginal Bleeding Clinical Trials

RWE Study in the Treatment of Cervical Lesions of Various Etiology

Start date: May 20, 2021
Phase:
Study type: Observational

The aim of the study was to assess the post-market performance and tolerability of Cerviron® ovules in the treatment and management of cervical lesions of different etiologies. The study included clinical data related to aspect of lesions performed during routine colposcopy exams, the degree of re-epithelialization of the cervical mucosa, vaginal pH, pain level, and vaginal bleeding level.

NCT ID: NCT05659433 Completed - Clinical trials for Retroperitoneal Neoplasms

Contrast-enhanced vs. B-mode Ultrasound-guided Percutaneous Biopsy of Retroperitoneal Tumors

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

Background: Retroperitoneal tumors are typically large and inhomogeneous, with a variable amount of necrosis within the tumor mass which decreases the diagnostic yield of biopsy (false negative or inadequate). Rationale: Real-time contrast enhancement can highlight the viable tumoral tissue and avoid the necrotic area. Aims: To compare contrast-enhanced ultrasound (CEUS) guidance and conventional (B-mode) ultrasound (US) guidance in terms of diagnostic yield, need for repeat biopsy, and rate of adverse events. Methods: A consecutive series of patients with previously documented retroperitoneal tumors and indications for percutaneous biopsy were randomly assigned to benefit from the standard of practice B-mode US-guided biopsy or CEUS-guided biopsy. The diagnostic accuracy, need for repeat biopsy, and adverse events were noted.

NCT ID: NCT05654610 Completed - Vaginal Atrophy Clinical Trials

Real-world Evidence Study on the Performance and Safety of Halova Ovules

Start date: March 1, 2022
Phase:
Study type: Observational

An open-label, multicentric, non-randomized, single-arm, pilot, interventional clinical investigation to confirm the tolerability and performance of the medical device Halova in lubrication of the vagina and vaginal atrophy treatment.

NCT ID: NCT05653908 Completed - Mental Health Issue Clinical Trials

REThinkAcademy: Helping Universities to Effectively Care for the Mental Health of College Students in the Digital Age

Start date: October 20, 2022
Phase: N/A
Study type: Interventional

The project aims at monitoring mental health and its mechanism in the student population using a longitudinal design and ecological momentary assessment procedure throughout the first semester of college.